FRBSX | JVMAX | FRBSX / JVMAX | |
Total Expense Ratio | 0.90 | 1.12 | 80% |
Annual Report Gross Expense Ratio | 0.92 | 1.13 | 81% |
Fund Existence | 35 years | 28 years | - |
Gain YTD | -7.390 | -8.576 | 86% |
Front Load | 6% | 5% | 110% |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 694M | 19.4B | 4% |
Annual Yield % from dividends | 1.24 | 0.61 | 202% |
Returns for 1 year | -4.40 | -11.80 | 37% |
Returns for 3 years | -7.17 | -9.16 | 78% |
Returns for 5 years | 37.83 | 45.43 | 83% |
Returns for 10 years | -21.39 | 18.32 | -117% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 24.36 | 0.35 | +1.46% |
First Trust Nasdaq Pharmaceuticals ETF | |||
PGZ | 10.13 | 0.12 | +1.20% |
PRINCIPAL REAL ESTATE Income FUND | |||
PFM | 43.48 | 0.24 | +0.56% |
Invesco Dividend Achievers™ ETF | |||
ISTB | 48.22 | N/A | +0.01% |
iShares Core 1-5 Year USD Bond ETF | |||
AMZY | 14.47 | -0.45 | -3.02% |
YieldMax AMZN Option Income Strategy ETF |